Late-stage biopharmaceutical company, Soligenix, Inc (Nasdaq: SNGX), has announced positive clinical results from a 12-week study of its lead product candidate, HyBryte™ (synthetic hypericin), which…
June 25, 2024
This month, precision diagnostics company, Oncocyte Corporation (Nasdaq: OCX) further strengthened its leadership team with the appointment of leading finance executive Andrea James as Chief…
Alto Neuroscience (NYSE: ANRO) has initiated a Phase 2 double-blind, placebo-controlled study of a transdermal formulation of ALTO-101 for the treatment of cognitive impairment associated…
Immunotherapy company, Enlivex Therapeutics (Nasdaq: ENLV), has released positive data from its Phase 1/2 investigator-initiated clinical trial of AllocetraTM in patients with end-stage knee osteoarthritis….
June 18, 2024
The GLP-1 Gold Rush Continues
A 2024 report from GlobalData has revealed that in spite of approaching headwinds in the obesity market, glucagon-like peptide-1 (GLP-1) receptor agonists will continue to…
MIRA Pharmaceuticals (Nasdaq: MIRA) is advancing closer to clinical development of what could potentially be the first at-home ketamine-based treatment for post-traumatic stress disorder (PTSD)….
Pharmaceutical company, Moleculin Biotech (Nasdaq: MBRX), has initiated an Investigator-initiated Phase 2 study evaluating WP1066 in combination with radiation therapy for the treatment of glioblastoma….
April 27, 2024
Challenging the Silence: Schizophrenia’s Economic Impact and the Latest in Clinical Trial Developments
Schizophrenia affects 1% of the US population but imposes a hefty economic burden of $176.3 billion each year made up of healthcare costs, lost tax…
Clinical stage biotechnology company, Lipella Pharmaceuticals (Nasdaq: LIPO) has been granted a Type C meeting request by the FDA. The company expects to meet with…
Shares in Nutriband (Nasdaq: NTRB) climbed nearly 50% in morning trading on Thursday after the company outlined its planned clinical and regulatory path for its…
March 28, 2024
Intelligent Scopes Brings AI to Colon Cancer Detection
Privately-held company, Intelligent Scopes Corporation, specializes in developing state-of-the-art image enhancement and precision AI software solutions for gastroenterology and urology. This month, the company announced…
Biopharmaceutical company, Axsome Therapeutics (Nasdaq: AXSM), has announced topline results from its CRESCENDO survey of patients with narcolepsy type 1 receiving treatment, demonstrating high rates…